january/february 2008

After fielding back-to-back complaints about masks in church—one regarding a fellow parishioner who had shirked a mask during a recent service and the other wondering whether our congregation had changed its policy from “strongly recommended” to “required,” because “everyone” was wearing them—I realized something surprising: Leading a church is harder now, in 2021, than it was in 2020, during the worst of the coronavirus pandemic. Last year, state and diocesan mandates meant I could throw up my hands and respond, “Sorry, not up to me.” And anyway, the answer was, for the most part, a straightforward “no”—no, we can’t gather for services, and no, we can’t sing. Now it is up to me, the rector of St. David’s Episcopal Church in Richmond, Virginia, and I am struggling to find a way forward.

The election of the elders of an evangelical church is usually an uncontroversial, even unifying event. But this summer, at an influential megachurch in Northern Virginia, something went badly wrong. A trio of elders didn’t receive 75 percent of the vote, the threshold necessary to be installed.  

“A small group of people, inside and outside this church, coordinated a divisive effort to use disinformation in order to persuade others to vote these men down as part of a broader effort to take control of this church,” David Platt, a 43-year-old minister at McLean Bible Church and a best-selling author, charged in a July 4 sermon.

Platt said church members had been misled, having been told, among other things, that the three individuals nominated to be elders would advocate selling the church building to Muslims, who would convert it into a mosque. In a second vote on July 18, all three nominees cleared the threshold. But that hardly resolved the conflict. Members of the church filed a lawsuit, claiming that the conduct of the election violated the church’s constitution.

Filipa Samarra could hear the pilot whales before she could see them. In 2015, out on the choppy waters off of southern Iceland, Samarra and her research team were eavesdropping on a group of killer whales. She listened as they pipped, squealed, and clicked when suddenly her ears were filled with high-pitched whistling. “Then the killer whales just went silent,” says Samarra, a biologist and the lead investigator of the Icelandic Orca Project. As the whistling grew stronger, a group of pilot whales came into view, and the killer whales seemed to turn and swim away.

“It’s quite unusual because the killer whale is this top predator,” says Anna Selbmann, a doctoral candidate at the University of Iceland who is supervised by Samarra. “It’s very unusual that they’re afraid of anything—or seemingly afraid.”

Ivermectin is an antiparasitic drug, and a very good one. If you are infected with the roundworms that cause river blindness or the parasitic mites that cause scabies, it is wonderfully effective. It is cheap; it is accessible; and its discoverers won the Nobel Prize in 2015. It has also been widely promoted as a coronavirus prophylactic and treatment.

This promotion has been broadly criticized as a fever dream conceived in the memetic bowels of the internet and as a convenient buttress for bad arguments against vaccination. This is not entirely fair. Perhaps 70 to 100 studies have been conducted on the use of ivermectin for treating or preventing COVID-19; several dozen of them support the hypothesis that the drug is a plague mitigant. Two meta-analyses, which looked at data aggregated across subsets of these studies, concluded that the drug has value in the fight against the pandemic.

In early March, Deepta Bhattacharya, an immunologist at the University of Arizona, celebrated a milestone: hitting the point of full vaccination, two weeks after getting his second Pfizer shot. Since then, he’s been watching the number of coronavirus antibodies in his blood slowly but surely decline.

The drop hasn’t been precipitous, but it’s definitely happening—regular checkups have shown his antibody levels, also known as titers, ticking down, down, down, from spring through summer, now into fall. The slump fits the narrative that countless reports have been sounding the alarm on for a while now: In the months after vaccination, our antibodies peace out, a trend that’s often been described as a “waning” of immunity, and evidence that we’re all in dire need of boosters to shore our defenses back up.